-
Science: CRISPR in the field of two "master" cooperation, deep analysis of single base editor off-target mechanism.
Time of Update: 2020-08-23
2016, David Liu developed the first mono-base editor to target and bind DNA without cutting DNA, replacing C-G base pairs with T-A base pairs.
" activity tests show that ABE8e is prone to more off-target editing because the deaminase proteins that fuse with Cas9 are always active.
-
The Chinese Academy of Sciences has teamed up with the City University of Hong Kong to develop microflow control chips for gastric cancer detection.
Time of Update: 2020-08-23
in the study, researchers developed a new microflow-controlled chip called photo-induced electrodynamics (OEK) that isolates live stomach cancer cells from the patient's abdominal water and characterifies their electrical properties.
-
Nat Commun: A key molecule in the immune escape of autophagy defects in tri-yin breast cancer.
Time of Update: 2020-08-23
In previous studies, the Zhu Xiaofeng Research Group and the Foreign Research Group of Sun Yat-sen University Cancer Prevention and Control Center have reported low protein expression levels in breast cancer of autophagy genes ULK1 and Beclin 1, respectively, and the low level of Beclin 1 mRNA can be an independent predictive indicator for TNBC patients.
-
A case of pulmonary primary melanoma.
Time of Update: 2020-08-23
This example of pulmonary melanoma MRI performance is typical, the lump boundary is clear, the fat-suppressing T1WI sequence is obviously high signal, T2WI signal is uneven, the lesions see flaky low signal area, is the melanin component, and the DWI sequence diffusion is obviously limited, in line with the characteristics of malignant tumors.
-
CA Cancer J Clin: Simplify cervical cancer screening, with changes in starting age and screening methods.
Time of Update: 2020-08-23
In this means that the new ACS guidelines are the first to use primary HPV screening alone, knowing that cytology screening has always been the gold standard for cervical cancer screening, and that the starting screening age is four years late compared to the current guidelines recommend starting screening at age 21.
-
What are the implications for the development of oncology in China in the 2020 clinical oncology school year?
Time of Update: 2020-08-18
(Health Times reporter Xu Wei, intern reporter Tan Qixin Qiu Yue Zhao Yuanji) " As the first live-streamed oncology event in 2020, i think it's a multidisciplinary alliance and a mutual promotion of t
-
Born with a tumor! Tongji Hospital removed a large liver tumor for newborns.
Time of Update: 2020-08-18
"Looking at this little man quietly acting like an angel, it's hard to imagine this being a child with a 10cm liver tumor at birth." Wu Xiaoxuan, an associate professor of pediatric surgery at Tongji Hospital at Huazhong University of Science and Technology, said with a smile.
-
Shenzhen has the first "national" cancer patient nutrition guidance center.
Time of Update: 2020-08-18
The Chinese Society of Clinical Oncology (CSCO) announced the first batch of 9 "national cancer patient nutrition guidance center" approved list, the Chinese Academy of Medical Sciences Oncology Hospi
-
Accurate prevention and treatment of brain tumors.
Time of Update: 2020-08-18
the "People's Famous Medical" to watch and ask questions as follows: sweep the two-dimensional code above to enter the Health Times WeChat live room, watch the live broadcast and online questions.
-
One-time positioning of tumor "life gate", the full target genetic detection to help target immunotherapy.
Time of Update: 2020-08-18
Professor Yang Fan pointed out that, like many other cancers, more molecular typed, so that the target type of genetic testing also increased, because the proportion of most genetic abnormalities is low, and even the proportion of many abnormal genes is less than 1%, at this time to accurately detect the mutation of lung cancer, need a "wide coverage", "high precision" gene detection products.
-
Tianjin has launched the project for early diagnosis and treatment of common malignancies in 2020.
Time of Update: 2020-08-18
it is understood that, in order to establish a cancer prevention and treatment system and long-term mechanism, since 2017, Tianjin piloted the project of early diagnosis and early treatment of common malignancies, carried out by the Tianjin Cancer Hospital, for more than 150,000 residents of cancer screening, found more than 11,000 high-risk groups, further review of confirmed cancer patients 103 cases.
-
Breakthrough therapy is here! China's first tumor electric field treatment on the market.
Time of Update: 2020-08-18
"In China, where more than 45,000 patients are diagnosed with glioblastoma each year, traditional surgery and chemotherapy have limited effect on the overall survival of patients and have long lacked
-
"Cure in music", so that the memory of children with tumors is not only the treatment.
Time of Update: 2020-08-18
nurse sister to help children paint body film activity on the day of the main play is "the cure in music" - let children first choose their favorite cartoon images, such as Altman, Spider-Man, Princess Anna, and then hand-painted themselves for radiotherapy fixed body film, not only, insist on each radiotherapy "punch" children after the treatment can also get their favorite gifts.
-
Female tumor prevention and treatment answer questions.
Time of Update: 2020-08-18
May 8is, World Ovarian Cancer Day, "People's Famous Medical" launched the World Ovarian Cancer Day special planning live broadcast, invited the expert in the field of gynaecological oncology, Fudan University affiliated obstetrics and gynecology hospital party secretary Hua Keqin and Nanjing Medical University First Affiliated Hospital (Jiangsu Provincial People's Hospital) Gynaecology Director Professor Cheng Wenjun for you to explain the relevant doubts about female tumors.
-
For the first time in 15 years! Tumor electro-field therapy has been approved for the treatment of glioblastoma.
Time of Update: 2020-08-18
On the evening of May 13, Reding Pharmaceuticals announced that China's State Drug Administration had approved the application for the application of the tumor electric field for the treatment of Epden for the treatment of newly diagnosed glioblastoma patients in conjunction with dimoamines, as well as for patients with recurrent glioma as a single therapy.
-
First case exceeds 200,000 malignancies survival report: 200,000 cases with 5-year total survival rate of 71%
Time of Update: 2020-08-18
(Health Times network reporter Wei Wei Fudan University affiliated oncology hospital Wang Guangchao Zhou Changming) . More than 200,000 cases of cancer, 10 years follow-up data, the total survival rat
-
A new strategy for cancer prevention and control in China.
Time of Update: 2020-08-18
On the occasion of the 26th National Cancer Prevention and Prevention Awareness Week (April 15th to April 22nd), the People's Daily Health Times client, the Chinese Society of Clinical Oncology (CSCO)
-
Live in the group! More than a hundred top tumor doctors online volunteer consultation field fully launched.
Time of Update: 2020-08-18
(Health Times reporter Dong Wei) . At the occasion of the 26th National Cancer Prevention and Control Awareness Week (April 15th to April 22nd), the large-scale public welfare project "People's Famous
-
Does the development of oncology drugs meet clinical needs? Expert: Far from it!
Time of Update: 2020-08-18
(Health Times reporter Qiao Jingfang) "For both doctors and patients, the development of Chinese cancer drugs is far from meeting clinical needs." On July 10, Professor Wang Wei of the Breast Center of Peking University People's Hospital said at the 2020 China Society of Clinical Oncology (CSCO) Annual Breast Cancer Conference and 2020 National Breast Cancer Conference.
-
Tumor immunotherapy market size of nearly 30 billion, Yongtai biological landing on the Hong Kong Stock Exchange.
Time of Update: 2020-08-18
Yongtai Bio Chairman Tan Wei said that the company, as the first biotech unit in Hong Kong to focus on cell immunotherapy, raised funds to support scientific and technological research and development and product commercialization, mainly to support core products and research and development pipeline research and development work, research and development pipelines and products to Europe and the United States.
